Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 55.46
(2.21%)
INR 55.46
(2.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 15.87 Million INR | 174.02% |
| 2022 | -18.08 Million INR | -251.47% |
| 2021 | 14.23 Million INR | 143.98% |
| 2020 | -19.66 Million INR | -467.79% |
| 2019 | 9.69 Million INR | 40.79% |
| 2018 | 8.1 Million INR | 49.33% |
| 2017 | 7.36 Million INR | 273.99% |
| 2016 | 888.29 Thousand INR | -45.73% |
| 2015 | 3.51 Million INR | -82.15% |
| 2014 | 8.62 Million INR | -5.01% |
| 2013 | 10.82 Million INR | -1.5% |
| 2012 | 10.2 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -1.96 Million INR | -262.28% |
| 2023 FY | - INR | 174.02% |
| 2023 Q4 | 8.47 Million INR | 56.24% |
| 2023 Q3 | 5.42 Million INR | 148.11% |
| 2023 Q2 | -11.27 Million INR | -474.57% |
| 2022 Q3 | -4.04 Million INR | 75.95% |
| 2022 Q1 | -16.89 Million INR | -363.59% |
| 2022 Q4 | 1.2 Million INR | 129.88% |
| 2022 Q2 | -16.82 Million INR | 0.41% |
| 2022 FY | - INR | -251.47% |
| 2021 Q3 | 5.35 Million INR | -67.19% |
| 2021 Q1 | -24.33 Million INR | -7565.64% |
| 2021 FY | - INR | 143.98% |
| 2021 Q4 | 6.41 Million INR | 19.79% |
| 2021 Q2 | 16.31 Million INR | 167.02% |
| 2020 Q3 | 1.9 Million INR | 157.39% |
| 2020 FY | - INR | -467.79% |
| 2020 Q2 | -3.32 Million INR | -20.97% |
| 2020 Q4 | 326 Thousand INR | -82.9% |
| 2020 Q1 | -2.74 Million INR | -158.86% |
| 2019 Q2 | -11.15 Million INR | -366.07% |
| 2019 FY | - INR | 40.79% |
| 2019 Q1 | 4.19 Million INR | -37.1% |
| 2019 Q3 | 18.54 Million INR | 266.22% |
| 2019 Q4 | 4.66 Million INR | -74.85% |
| 2018 Q4 | 6.66 Million INR | 168.83% |
| 2018 FY | - INR | 49.33% |
| 2018 Q3 | 2.48 Million INR | 145.83% |
| 2018 Q2 | -5.41 Million INR | -329.86% |
| 2018 Q1 | 2.35 Million INR | -46.49% |
| 2017 Q1 | -278 Thousand INR | -125.34% |
| 2017 Q3 | 12.91 Million INR | 204.97% |
| 2017 Q4 | 4.39 Million INR | -65.93% |
| 2017 Q2 | -12.3 Million INR | -4324.46% |
| 2017 FY | - INR | 273.99% |
| 2016 FY | - INR | -45.73% |
| 2016 Q3 | 12.43 Million INR | 254.72% |
| 2016 Q4 | 1.09 Million INR | -91.18% |
| 2016 Q2 | -8.03 Million INR | -175.42% |
| 2016 Q1 | 10.65 Million INR | 574.44% |
| 2015 Q4 | -2.24 Million INR | -220.86% |
| 2015 FY | - INR | -82.15% |
| 2015 Q1 | 2.81 Million INR | 31.87% |
| 2015 Q2 | -4.17 Million INR | -248.15% |
| 2015 Q3 | -700 Thousand INR | 83.24% |
| 2014 Q1 | 5.27 Million INR | 160.55% |
| 2014 FY | - INR | -5.01% |
| 2014 Q4 | 2.13 Million INR | -20.07% |
| 2014 Q3 | 2.67 Million INR | 305.92% |
| 2014 Q2 | 659 Thousand INR | -87.5% |
| 2013 Q1 | 3.73 Million INR | 34.75% |
| 2013 FY | - INR | -1.5% |
| 2013 Q3 | 4.13 Million INR | 581.28% |
| 2013 Q2 | -860 Thousand INR | -123.01% |
| 2013 Q4 | 2.02 Million INR | -51.1% |
| 2012 Q2 | 2.1 Million INR | 30.14% |
| 2012 Q4 | 2.77 Million INR | -15.12% |
| 2012 FY | - INR | 0.0% |
| 2012 Q1 | 1.61 Million INR | -20.68% |
| 2012 Q3 | 3.26 Million INR | 55.1% |
| 2011 Q3 | 5.59 Million INR | 0.0% |
| 2011 Q4 | 2.04 Million INR | -63.49% |
| 2010 Q1 | 2.83 Million INR | 0.0% |
| 2009 Q1 | 1.6 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | 82.488% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 80.782% |
| Bacil Pharma Limited | -569.32 Thousand INR | 2888.766% |
| Beryl Drugs Limited | 26.63 Million INR | 40.399% |
| Cian Healthcare Limited | 122.56 Million INR | 87.046% |
| Colinz Laboratories Limited | 5.42 Million INR | -192.502% |
| Concord Drugs Limited | 40.52 Million INR | 60.817% |
| Deccan Health Care Limited | 37.5 Million INR | 57.668% |
| Gennex Laboratories Limited | 219.35 Million INR | 92.762% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -33.555% |
| Kerala Ayurveda Limited | 70.78 Million INR | 77.571% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 97.399% |
| Mercury Laboratories Limited | 101.18 Million INR | 84.309% |
| Panchsheel Organics Limited | 189.36 Million INR | 91.616% |
| Parmax Pharma Limited | 22.93 Million INR | 30.781% |
| Parnax Lab Limited | 243.59 Million INR | 93.482% |
| Patidar Buildcon Limited | -5.52 Million INR | 387.315% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 112.879% |
| Phaarmasia Limited | -1.58 Million INR | 1103.603% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 41.614% |
| Sastasundar Ventures Limited | -203.51 Million INR | 107.801% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 82.163% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 64.563% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 93.753% |
| Sunil Healthcare Limited | 93.07 Million INR | 82.942% |
| Syschem (India) Limited | 70.4 Million INR | 77.448% |
| Trident Lifeline Limited | 102.69 Million INR | 84.539% |
| Transchem Limited | 56.61 Million INR | 71.954% |
| Tyche Industries Limited | 128.2 Million INR | 87.616% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 95.897% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 81.15% |
| Zenith Healthcare Limited | 4.98 Million INR | -218.304% |
| Zenotech Laboratories Limited | 172.64 Million INR | 90.804% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -2385.62% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -37.06% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 3.881% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.597% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 81.872% |
| Smruthi Organics Limited | 120.31 Million INR | 86.803% |
| Trimurthi Limited | -2.47 Million INR | 740.586% |
| Zenlabs Ethica Limited | 27.09 Million INR | 41.405% |
| Makers Laboratories Limited | 25.81 Million INR | 38.49% |
| Lactose (India) Limited | 201.22 Million INR | 92.11% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 110.511% |
| Roopa Industries Limited | 55.7 Million INR | 71.496% |
| PANJON LTD. | 4.08 Million INR | -288.286% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 183.335% |
| Anuh Pharma Limited | 878.5 Million INR | 98.193% |
| Crestchem Limited | 30.33 Million INR | 47.66% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 246.765% |
| PRAVEG LIMITED | 321.43 Million INR | 95.061% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 95.918% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 92.67% |
| Norris Medicines Limited | -1.78 Million INR | 989.894% |
| Denis Chem Lab Limited | 224.84 Million INR | 92.939% |
| Veerhealth Care Limited | 15.99 Million INR | 0.738% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 95.798% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 116.509% |
| Godavari Drugs Limited | 134.62 Million INR | 88.206% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 4010.591% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 90.692% |
| Vivanza Biosciences Limited | 11.2 Million INR | -41.708% |
| Medi-Caps Limited | 4.77 Million INR | -232.781% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 683.713% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 96.462% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 98.089% |
| Bharat Parenterals Limited | 265.74 Million INR | 94.025% |
| BDH Industries Limited | 124.27 Million INR | 87.224% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 149.035% |
| Coral Laboratories Limited | 227.07 Million INR | 93.008% |
| Evoq Remedies Limited | 6.18 Million INR | -156.578% |
| Trinity League India Limited | -26.25 Million INR | 160.477% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 285.198% |
| Natural Capsules Limited | 219.9 Million INR | 92.78% |
| Auro Laboratories Limited | 121.73 Million INR | 86.958% |